PL1931316T5 - Kompozycje farmaceutyczne o kontrolowanym uwalnianiu dla leków labilnych kwasowo - Google Patents
Kompozycje farmaceutyczne o kontrolowanym uwalnianiu dla leków labilnych kwasowoInfo
- Publication number
- PL1931316T5 PL1931316T5 PL06778240T PL06778240T PL1931316T5 PL 1931316 T5 PL1931316 T5 PL 1931316T5 PL 06778240 T PL06778240 T PL 06778240T PL 06778240 T PL06778240 T PL 06778240T PL 1931316 T5 PL1931316 T5 PL 1931316T5
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical compositions
- acid labile
- controlled release
- release pharmaceutical
- enteric
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70869205P | 2005-08-15 | 2005-08-15 | |
EP05107472 | 2005-08-15 | ||
PCT/EP2006/065311 WO2007020259A2 (en) | 2005-08-15 | 2006-08-15 | Controlled release pharmaceutical compositions for acid labile drugs |
EP06778240.9A EP1931316B2 (en) | 2005-08-15 | 2006-08-15 | Controlled release pharmaceutical compositions for acid labile drugs |
Publications (2)
Publication Number | Publication Date |
---|---|
PL1931316T3 PL1931316T3 (pl) | 2010-07-30 |
PL1931316T5 true PL1931316T5 (pl) | 2017-10-31 |
Family
ID=35253818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06778240T PL1931316T5 (pl) | 2005-08-15 | 2006-08-15 | Kompozycje farmaceutyczne o kontrolowanym uwalnianiu dla leków labilnych kwasowo |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1931316B2 (pl) |
JP (1) | JP5452918B2 (pl) |
CN (1) | CN101242811B (pl) |
AT (1) | ATE457719T2 (pl) |
AU (1) | AU2006281414B2 (pl) |
BR (1) | BRPI0614545B8 (pl) |
CA (1) | CA2619475C (pl) |
DK (1) | DK1931316T4 (pl) |
ES (1) | ES2341284T5 (pl) |
MX (1) | MX2008001558A (pl) |
NZ (1) | NZ565960A (pl) |
PL (1) | PL1931316T5 (pl) |
PT (1) | PT1931316E (pl) |
RU (1) | RU2440101C2 (pl) |
SI (2) | SI1931316T1 (pl) |
UA (1) | UA92030C2 (pl) |
WO (1) | WO2007020259A2 (pl) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1319655B1 (it) | 2000-11-15 | 2003-10-23 | Eurand Int | Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione. |
CA2616943C (en) | 2005-07-29 | 2016-04-12 | Solvay Pharmaceuticals Gmbh | Processes for the manufacture of sterilized pancreatin powder |
US11266607B2 (en) | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US10072256B2 (en) | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
PT2079445E (pt) * | 2007-02-20 | 2016-02-29 | Allergan Pharmaceuticals Internat Ltd | Composições de enzimas digestivas estáveis |
EP2044932A1 (en) | 2007-10-04 | 2009-04-08 | Laboratorios del Dr. Esteve S.A. | Mechanical protective layer for solid dosage forms |
EP3574914B1 (en) | 2007-11-13 | 2021-12-29 | ViroPharma Biologics LLC | Corticosteroid compositions |
WO2009109856A2 (en) | 2008-03-07 | 2009-09-11 | Axcan Pharma Inc. | Method for detecting infectious parvovirus in pharmaceutical preparations |
EP2440210A4 (en) | 2009-06-12 | 2014-01-29 | Meritage Pharma Inc | METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES |
CN102946872A (zh) * | 2010-05-03 | 2013-02-27 | 阿普塔利斯制药有限公司 | 包含含有胰酶的消化酶混合物的微丸组合物 |
CN103221036A (zh) | 2010-10-01 | 2013-07-24 | 阿普塔利斯制药有限公司 | 肠溶包衣的低强度胰脂肪酶制剂 |
DK2741766T3 (en) * | 2011-08-08 | 2016-01-11 | Aptalis Pharma Ltd | Process for dissolving solid compositions containing digestive enzymes |
CA2920844A1 (en) | 2013-08-09 | 2015-02-12 | Allergan Pharmaceuticals International Limited | Digestive enzyme composition suitable for enteral administration |
AU2015275860A1 (en) | 2014-06-19 | 2016-11-03 | Aptalis Pharma Ltd. | Methods for removing viral contaminants from pancreatic extracts |
RU2712142C2 (ru) | 2014-11-05 | 2020-01-24 | Эбботт Лабораторис Гмбх | Способы получения композиций с улучшенным профилем безопасности, содержащих панкреатин, и композиции, пригодные для фармацевтического применения |
CN104906565B (zh) * | 2015-05-13 | 2018-06-19 | 西南大学 | 一种胰酶肠溶微丸及其制备方法 |
CN105902513B (zh) * | 2016-05-11 | 2018-10-16 | 广州市义和化工有限公司 | 一种肠溶型金霉素微丸预混剂及其制备方法 |
CN108553439B (zh) * | 2018-04-20 | 2020-10-16 | 广州白云山医药集团股份有限公司白云山制药总厂 | 一种含s-羧甲基-l-半胱氨酸的肠溶片剂 |
RU2706003C1 (ru) * | 2019-09-09 | 2019-11-13 | Акционерное общество "АВВА РУС" | Микрогранулы, содержащие панкреатин |
KR102432084B1 (ko) * | 2021-11-16 | 2022-08-12 | 알리코제약(주) | S-오메프라졸을 함유하는 안정성이 개선되고 소형화된 정제 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2923279B1 (de) | 1979-06-08 | 1980-11-20 | Kali Chemie Pharma Gmbh | Verfahren zur Herstellung von Pankreatin-Pellets |
JPS5855125B2 (ja) * | 1980-03-10 | 1983-12-08 | 信越化学工業株式会社 | 固形薬剤用腸溶性コ−テイング剤組成物 |
JPS57171428A (en) | 1981-04-13 | 1982-10-22 | Sankyo Co Ltd | Preparation of coated solid preparation |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
US5225202A (en) | 1991-09-30 | 1993-07-06 | E. R. Squibb & Sons, Inc. | Enteric coated pharmaceutical compositions |
DE4227385A1 (de) | 1992-08-19 | 1994-02-24 | Kali Chemie Pharma Gmbh | Pankreatinmikropellets |
JP2917799B2 (ja) | 1994-03-11 | 1999-07-12 | 田辺製薬株式会社 | 消化管内適所放出型製剤 |
JP3355593B2 (ja) | 1994-08-19 | 2002-12-09 | 信越化学工業株式会社 | 固形腸溶製剤の製造方法 |
JP3435464B2 (ja) * | 1995-01-23 | 2003-08-11 | 信越化学工業株式会社 | 徐放性製剤コーティング用水分散液 |
SE512835C2 (sv) * | 1996-01-08 | 2000-05-22 | Astrazeneca Ab | Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare |
JP3611456B2 (ja) * | 1997-09-30 | 2005-01-19 | 日研化学株式会社 | テオフィリン徐放性錠剤 |
KR19990072826A (ko) * | 1998-02-26 | 1999-09-27 | 우재영 | 판크레아틴장용코팅과립의제조방법 |
UA69413C2 (uk) | 1998-05-22 | 2004-09-15 | Брістол-Майерс Сквібб Компані | Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції |
DK1162995T3 (da) | 1999-03-17 | 2003-06-23 | Solvay Pharm Gmbh | Enzymer til behandling af diabetes mellitus type I |
US20020146451A1 (en) | 2000-07-15 | 2002-10-10 | Sharma Virender K. | Method for the administration of acid-labile drugs |
IT1319655B1 (it) * | 2000-11-15 | 2003-10-23 | Eurand Int | Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione. |
US20040213847A1 (en) * | 2003-04-23 | 2004-10-28 | Matharu Amol Singh | Delayed release pharmaceutical compositions containing proton pump inhibitors |
-
2006
- 2006-08-15 UA UAA200803186A patent/UA92030C2/ru unknown
- 2006-08-15 WO PCT/EP2006/065311 patent/WO2007020259A2/en active Application Filing
- 2006-08-15 CA CA2619475A patent/CA2619475C/en active Active
- 2006-08-15 RU RU2008109652/15A patent/RU2440101C2/ru active
- 2006-08-15 DK DK06778240.9T patent/DK1931316T4/en active
- 2006-08-15 MX MX2008001558A patent/MX2008001558A/es active IP Right Grant
- 2006-08-15 PT PT06778240T patent/PT1931316E/pt unknown
- 2006-08-15 ES ES06778240.9T patent/ES2341284T5/es active Active
- 2006-08-15 PL PL06778240T patent/PL1931316T5/pl unknown
- 2006-08-15 EP EP06778240.9A patent/EP1931316B2/en active Active
- 2006-08-15 AT AT06778240T patent/ATE457719T2/de active
- 2006-08-15 NZ NZ565960A patent/NZ565960A/en unknown
- 2006-08-15 SI SI200630639T patent/SI1931316T1/sl unknown
- 2006-08-15 SI SI200630639A patent/SI1931316T2/sl unknown
- 2006-08-15 AU AU2006281414A patent/AU2006281414B2/en active Active
- 2006-08-15 CN CN200680029688.XA patent/CN101242811B/zh active Active
- 2006-08-15 BR BRPI0614545A patent/BRPI0614545B8/pt active IP Right Grant
- 2006-08-15 JP JP2008526492A patent/JP5452918B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP5452918B2 (ja) | 2014-03-26 |
CA2619475A1 (en) | 2007-02-22 |
EP1931316A2 (en) | 2008-06-18 |
CA2619475C (en) | 2015-09-29 |
AU2006281414A1 (en) | 2007-02-22 |
CN101242811B (zh) | 2015-06-17 |
RU2440101C2 (ru) | 2012-01-20 |
EP1931316B2 (en) | 2017-02-22 |
UA92030C2 (ru) | 2010-09-27 |
WO2007020259A3 (en) | 2007-05-10 |
ES2341284T3 (es) | 2010-06-17 |
PL1931316T3 (pl) | 2010-07-30 |
EP1931316B1 (en) | 2010-02-17 |
RU2008109652A (ru) | 2009-09-27 |
DK1931316T3 (da) | 2010-05-17 |
ES2341284T5 (es) | 2017-09-05 |
BRPI0614545A2 (pt) | 2011-04-05 |
BRPI0614545B8 (pt) | 2021-05-25 |
WO2007020259A2 (en) | 2007-02-22 |
JP2009504709A (ja) | 2009-02-05 |
SI1931316T1 (sl) | 2010-06-30 |
MX2008001558A (es) | 2008-02-15 |
BRPI0614545B1 (pt) | 2020-03-31 |
PT1931316E (pt) | 2010-03-29 |
AU2006281414B2 (en) | 2011-09-01 |
NZ565960A (en) | 2012-03-30 |
SI1931316T2 (sl) | 2017-05-31 |
CN101242811A (zh) | 2008-08-13 |
DK1931316T4 (en) | 2017-05-15 |
ATE457719T2 (de) | 2010-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1931316T5 (pl) | Kompozycje farmaceutyczne o kontrolowanym uwalnianiu dla leków labilnych kwasowo | |
WO2008132712A3 (en) | Combination pharmaceutical compositions | |
WO2017171535A8 (en) | Compositions | |
WO2004062577A3 (en) | Two or more enteric materials to regulate drug release | |
MX2023006541A (es) | Formulaciones de dosis fija. | |
WO2008063910A3 (en) | Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions | |
EA201892836A1 (ru) | Составы 2-[3-[4-амино-3-(2-фтор-4-феноксифенил)пиразол[3,4-d]пиримидин-1-ил]пиперидин-1-карбонил]-4-метил-4-[4-(оксетан-3-ил)пиперазин-1-ил]пент-2-еннитрила с модифицированным высвобождением | |
WO2014170755A3 (en) | Sustained-release formulations of colchicine and methods of using same | |
WO2009117130A3 (en) | Extended release forumulation containing a wax | |
EA201071035A1 (ru) | Фармацевтические композиции модифицированного высвобождения, содержащие микофенолат, и способ их получения | |
WO2007075794A3 (en) | Oral formulations comprising tigecycline | |
PH12019500154A1 (en) | Formulation having improved ph-dependent drug-release characteristics, containing esomeprazole or pharmaceutically acceptable salt thereof | |
WO2006127321A3 (en) | Formulations of suberoylanilide hydroxamic acid and methods for producing same | |
WO2016126058A3 (ko) | 두타스테라이드 함유 고체 분산체 및 이를 포함하는 조성물 | |
WO2008039894A3 (en) | Atorvastatin pharmaceutical compositions | |
WO2008122994A3 (en) | Stable pharmaceutical compositions of clopidogrel bisulfate and process of preparation thereof | |
WO2009150238A3 (en) | Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives | |
WO2020032885A3 (en) | Capsule-in-capsule compositions of dabigatran etexilate | |
NZ596275A (en) | Burst drug release compositions | |
EP3849560A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE CONTROLLED RELEASE OF WEAK ACID DRUGS AND THEIR USES | |
WO2016091805A3 (de) | Naloxon-monopräparat und mehrschichttablette | |
WO2018069805A3 (en) | Method for preparation of liquid oral composition of l-thyroxin | |
WO2005082371A3 (fr) | Composition amaigrissante par voie orale comprenant de l’acide linoleique conjugue et de la cafeine | |
MX2019015869A (es) | Nuevas formulaciones orales de belinostat. | |
JP2016504390A5 (pl) |